Ingevity Analyst Ratings
Wells Fargo Maintains Equal-Weight on Ingevity, Lowers Price Target to $32
BMO Capital Maintains Ingevity(NGVT.US) With Buy Rating, Cuts Target Price to $50
Ingevity Analyst Ratings
BMO Capital Upgrades Ingevity to Outperform, Raises Price Target to $65
BMO Capital Upgrades Ingevity(NGVT.US) to Buy Rating, Raises Target Price to $65
Analysts Offer Insights on Materials Companies: Anglogold Ashanti PLC (AU) and Ingevity (NGVT)
Ingevity Is Maintained at Market Perform by BMO Capital
Ingevity Analyst Ratings
BMO Capital Maintains Ingevity(NGVT.US) With Hold Rating, Raises Target Price to $62
Wells Fargo Maintains Ingevity(NGVT.US) With Hold Rating, Raises Target Price to $45
Ingevity Analyst Ratings
Ingevity Price Target Raised to $47.00/Share From $40.00 by BMO Capital
Ingevity Is Maintained at Market Perform by BMO Capital
BMO Capital Maintains Ingevity(NGVT.US) With Hold Rating, Cuts Target Price to $40
Wells Fargo Maintains Ingevity(NGVT.US) With Hold Rating, Maintains Target Price $40
Wells Fargo Maintains Ingevity(NGVT.US) With Hold Rating, Maintains Target Price $40
Wells Fargo Maintains Ingevity(NGVT.US) With Hold Rating, Cuts Target Price to $40
Ingevity's Leadership Transition: Navigating Uncertainties and Maintaining a Hold Rating
Jefferies Maintains Ingevity(NGVT.US) With Buy Rating, Maintains Target Price $53